Cargando…
A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered on an unprecedented scale. Assessing the risks of side effects is needed to aid clinicians in early detection and treatment. This study examined the risk of inflammatory heart disease, including...
Autores principales: | Knowlton, Kirk U, Knight, Stacey, Muhlestein, Joseph B, Le, Viet T, Horne, Benjamin D, May, Heidi T, Stenehjem, Edward A, Anderson, Jeffrey L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755376/ https://www.ncbi.nlm.nih.gov/pubmed/35141346 http://dx.doi.org/10.1093/ofid/ofab663 |
Ejemplares similares
-
DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021) -
A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023) -
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021) -
Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023) -
IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)